These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18323765)

  • 1. What we have learned about sleep disorders and psychosis after nearly two centuries of Parkinson's disease. Summary and conclusions.
    Fernandez HH
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):34-5. PubMed ID: 18323765
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosis in Parkinson's disease.
    Poewe W
    Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment.
    Mehta SH; Morgan JC; Sethi KD
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):6-11. PubMed ID: 18323761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease].
    Krüger R; Weiss D
    MMW Fortschr Med; 2011 Apr; 153(14):29-32; quiz 33. PubMed ID: 21966866
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson's disease psychosis: presentation, diagnosis and management.
    Schneider RB; Iourinets J; Richard IH
    Neurodegener Dis Manag; 2017 Dec; 7(6):365-376. PubMed ID: 29160144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimavanserin (Nuplazid) for Parkinson's disease psychosis.
    Med Lett Drugs Ther; 2016 Jun; 58(1496):74-5. PubMed ID: 27249096
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evidence-based treatment of psychosis associated with Parkinson's disease].
    Haussmann R; Bauer M; Donix M
    Nervenarzt; 2016 May; 87(5):543-51. PubMed ID: 26643499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking a closer look at sleep problems and psychosis in Parkinson's disease. Introduction.
    Fernandez HH
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):4-5. PubMed ID: 18323760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parkinson's disease and psychoses].
    Bizzarri JV; Giupponi G; Maniscalco I; Schroffenegger P; Conca A; Kapfhammer HP
    Neuropsychiatr; 2015; 29(1):1-13. PubMed ID: 25586068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective?
    Zahodne LB; Fernandez HH
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):26-33. PubMed ID: 18323764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Weintraub D; Hurtig HI
    Am J Psychiatry; 2007 Oct; 164(10):1491-8. PubMed ID: 17898337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive daytime sleepiness in Parkinson's disease.
    Schapira AH
    Neurology; 2004 Oct; 63(8 Suppl 3):S24-7. PubMed ID: 15505139
    [No Abstract]   [Full Text] [Related]  

  • 15. Pimavanserin for Parkinson Disease Psychosis.
    Mohanty D; Sarai S; Naik S; Lippmann S
    Prim Care Companion CNS Disord; 2019 Apr; 21(2):. PubMed ID: 31050230
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
    Fénelon G
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depressive syndrome, psychoses, dementia: frequent manifestations in Parkinson disease].
    Wedekind S
    MMW Fortschr Med; 2005 Jun; 147(22):11. PubMed ID: 15977623
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nocturnal motor symptoms of Parkinson's disease and their treatment with the three-component drug levodopa/carbidopa/entacapone].
    Kulua TK; Fedorova NV; Popovkina OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9 Pt 2):45-50. PubMed ID: 22027607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole-induced psychosis in Parkinson's disease.
    Li CT; Tsai SJ; Hwang JP
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):245. PubMed ID: 18412854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.